Clinical Trial Update: Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Exploratory Efficacy of a Vaccine Against Essential Hypertension [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 study evaluating a vaccine against essential hypertension, focusing on safety, tolerability, pharmacodynamic ef…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Snippet

Sponsor: Cytos Biotechnology AG | Conditions: Hypertension | Phase 2 | Status: COMPLETED